Responses
Poster Presentations
Rheumatoid arthritis - non biologic treatment
THU0213 Comparative efficacy and safety of baricitinib 2 MG and 4 MG in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials
Compose a Response to This Article
Other responses
No responses have been published for this article.